http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1169858-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate | 1982-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1984-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a47591705a93950d715780d7806f4be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_129e6f504ef6e1889f7a2ec4245a21fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57312562dd66865908ef20fee85f8692 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc42aeacd1c6c3ec54bd8835782baf42 |
| publicationDate | 1984-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1169858-A |
| titleOfInvention | Heterocyclic compounds, the preparation and use thereof |
| abstract | Abstract The lnvention relates to dibenzazepine derivatives of formula (I) (I) and the prsparation and use thereof. In formula (I), R1, R2, R3 and R4 represent hydrogen or halogen, or an alkyl or alkoxy group, each with 1 to 6 carbon atoms, R5 represents hydrogen, alkyl with 1 to 6 carbon atoms or alkenyl with 3 to 6 carbon atoms, R6 represents alkyl with 1 to 6 carbon atoms, alkenyl with 3 to 6 carbon atoms, a phenyl group optionally substituted by halogen, alkyl or alkoxy groups, or an optionally substituted phenylalkyl group witb the partial formula , wherein R1' and R2' may have the same meanings as. R1 and R2 but need not be identical to them, and n represents one of the integers from 0 to 4, X represents O, S or CH2, and the dotted line indicates the presence of either a single or a double bond. Compounds which have an asymmetric carbon atom may occur as racemates, as pure enantiomers or as mixtures containing differing proportions of the enantiomers. The compounds may occur in the form of the free bases or the acid addition salts. The new compounds have an anti-allergic, anti-histaminic and anti-serotonin activity and may therefore be used as medicaments. |
| priorityDate | 1981-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.